News

The company has posted net loss of C$15.35m, as compared to net loss of C$1.59m for the year ago period. The basic and fully-diluted net loss per share

The US Food and Drug Administration (FDA) approved Aquoral is indicated for the treatment of xerostomia. PediatRx founder Cameron Durrant said they expect that Aquoral will help further

Vibativ is an once-daily injectable lipoglycopeptide antibacterial agent with a dual mechanism of action against Gram-positive bacteria, including resistant pathogens such as methicillin-resistant Staphylococcus aureus (MRSA). Astellas Pharma

In two Phase 1a studies, AVL-292 demonstrated a favorable safety, tolerability and pharmacokinetic profile in healthy volunteers. The trial is investigating the pharmacokinetics, safety and tolerability profile of

The grant is expected to support the validation and prioritization of several lead CFCL chemical classes, drugs targeting the most common cystic fibrosis (CF) disease-causing mutation. DBM expects

iCentera is a provider of SaaS-based sales enablement solutions. The iCentera platform provides easy-to-use solutions for business users that incorporate automated content management, portal creation, and built-in trend

Thorne Bariatric nutritional product line is made of natural sweeteners and flavorings and is aspartame-free and sucralose-free. The product line includes ImmunoLin, which enhances gastrointestinal and immune health

The company expects to recruit around 225 patients in the study to investigate the efficacy and safety of weekly injections of CJC-1134-PC for 17 weeks. The trial also

The study also demonstrated that vildagliptin added to current therapy resulted in significant improvements in glycemic control. The data showed that the overall safety and tolerability of vildagliptin